1. Home
  2. PROV vs RCEL Comparison

PROV vs RCEL Comparison

Compare PROV & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

HOLD

Current Price

$16.00

Market Cap

98.1M

Sector

Finance

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.50

Market Cap

102.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
RCEL
Founded
1956
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.1M
102.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
PROV
RCEL
Price
$16.00
$3.50
Analyst Decision
Hold
Buy
Analyst Count
2
5
Target Price
$16.25
$11.75
AVG Volume (30 Days)
10.1K
205.1K
Earning Date
01-27-2026
11-06-2025
Dividend Yield
3.51%
N/A
EPS Growth
N/A
N/A
EPS
0.90
N/A
Revenue
$39,823,000.00
$72,401,000.00
Revenue This Year
$4.14
$13.12
Revenue Next Year
$3.70
$27.56
P/E Ratio
$17.77
N/A
Revenue Growth
0.07
20.59
52 Week Low
$12.98
$3.25
52 Week High
$16.65
$14.16

Technical Indicators

Market Signals
Indicator
PROV
RCEL
Relative Strength Index (RSI) 60.82 43.10
Support Level $15.76 $3.25
Resistance Level $16.24 $3.58
Average True Range (ATR) 0.40 0.17
MACD 0.09 0.01
Stochastic Oscillator 78.86 44.00

Price Performance

Historical Comparison
PROV
RCEL

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: